Our Pricing

Mounjaro Dosing Timeline: What Happens Week by Week

Published on: June 03, 2026

Understanding the mounjaro dosing schedule UK is essential for safe, effective weight loss with tirzepatide. At Cured Pharmacy, our UK-registered prescribers guide you through each dose escalation stage, from the initial 2.5mg starter dose to the maximum 15mg maintenance dose. This week-by-week timeline explains exactly what to expect at each stage of your Mounjaro treatment journey.

How Mounjaro Dosing Works: The Gradual Escalation Principle

Mounjaro (tirzepatide) follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst maximising weight loss efficacy [1]. Unlike medications with fixed dosing, tirzepatide requires a gradual four-week step-up approach at each dose level, allowing your body to adapt to increasing concentrations of the dual GIP/GLP-1 receptor agonist.

The MHRA-approved dosing schedule begins at 2.5mg once weekly for four weeks, then increases by 2.5mg increments every four weeks until reaching your target maintenance dose [1]. This gradual approach was validated in the SURPASS clinical trial programme, which demonstrated significantly lower rates of nausea and vomiting compared to immediate higher-dose initiation [2].

Your UK prescriber at Cured Pharmacy will determine your optimal maintenance dose based on your weight loss response, tolerability, and clinical goals. Most patients reach therapeutic benefit between 10mg and 15mg weekly, though some achieve their targets at lower doses [1]. The key principle is patience—rushing dose escalation increases side effect risk without improving long-term outcomes.

Weeks 1-4: Starting with Mounjaro 2.5mg

Your Mounjaro journey begins with the 2.5mg starter dose, administered as a single subcutaneous injection once weekly for four consecutive weeks [1]. This initial dose is intentionally sub-therapeutic for weight loss—its primary purpose is to allow your gastrointestinal system to adapt to tirzepatide's appetite-suppressing effects.

During these first four weeks, you may notice mild appetite reduction and early satiety, though significant weight loss is uncommon at this starter dose. Clinical trial data shows average weight reduction of 2-3% during the 2.5mg phase [2]. Common experiences include mild nausea (typically resolving within 48-72 hours post-injection), slight changes in bowel habits, and reduced food cravings between meals.

It's crucial to maintain your injection schedule on the same day each week, allowing a consistent 7-day interval between doses. If you experience persistent nausea, eating smaller, more frequent meals and avoiding high-fat foods can help. Your Cured Pharmacy clinical team remains available throughout this initiation period to address any concerns before your first dose increase.

What to Expect in Your First Month

The 2.5mg phase serves as your body's adjustment period. Most patients report feeling fuller after smaller portions, though hunger suppression is less pronounced than at higher doses. Gastrointestinal side effects, if they occur, are typically mildest during this starter phase and improve significantly by week three or four [2]. Focus on establishing your weekly injection routine and monitoring how your body responds before escalating to 5mg.

Weeks 5-8: Increasing to Mounjaro 5mg

After completing four weeks at 2.5mg, you'll escalate to 5mg once weekly for the next four-week period [1]. This first dose increase often marks the transition from adaptation to therapeutic effect, with many patients experiencing more noticeable appetite suppression and accelerated weight loss.

Clinical data from the SURMOUNT-1 trial showed average weight reduction of 5-7% by week eight on the 5mg dose, compared to 2-3% at baseline [2]. You may notice increased satiety lasting 3-4 days post-injection, reduced interest in snacking, and earlier fullness during meals. Gastrointestinal side effects may temporarily intensify during the first 1-2 weeks at 5mg before settling to baseline levels.

This dose represents the minimum therapeutic level for some patients, though most will continue escalating to achieve optimal results. Your UK prescriber will assess your four-week response at 5mg—including total weight loss, side effect profile, and adherence—before approving progression to 7.5mg. If you're experiencing excellent results with minimal side effects, continuing escalation is typically recommended.

Weeks 9-12: Progressing to Mounjaro 7.5mg

The 7.5mg dose level, administered weekly for four weeks, represents a mid-range therapeutic dose where many patients begin seeing substantial weight loss momentum [1]. By this stage, your body has adapted to tirzepatide's dual-receptor mechanism, and the appetite-suppressing effects become more consistent throughout the week.

Trial participants at 7.5mg reported average weight reduction of 10-12% from baseline by week twelve, with peak satiety effects occurring 24-72 hours post-injection [2]. You may find yourself naturally choosing smaller portions, experiencing reduced food noise (intrusive thoughts about eating), and feeling satisfied with significantly fewer calories than pre-treatment.

Gastrointestinal tolerance is generally well-established by this dose, though some patients experience transient nausea for 24-48 hours following each injection. Staying well-hydrated, avoiding large meals immediately after injection day, and eating protein-rich foods can optimise tolerability. Your Cured Pharmacy prescriber will evaluate whether 7.5mg serves as your maintenance dose or if further escalation to 10mg is appropriate based on your individualised treatment goals.

Recognising Therapeutic Response at 7.5mg

By week twelve, you should have lost at least 5% of your starting body weight to be considered a treatment responder [1]. If you've achieved this threshold with good tolerability, your prescriber may recommend continuing at 7.5mg as your maintenance dose rather than escalating further. However, if weight loss has plateaued or you're tolerating the medication well, progression to 10mg often produces additional benefit without significantly increased side effects.

Weeks 13-16: Advancing to Mounjaro 10mg

The 10mg weekly dose represents the first of two maximum-strength options and is the maintenance dose for many patients achieving their weight loss targets [1]. At this level, tirzepatide's dual GIP/GLP-1 activity reaches near-maximal receptor engagement, producing robust appetite suppression and metabolic effects.

SURMOUNT-1 data demonstrated average weight reduction of 15-18% at the 10mg dose by week 72, with most weight loss occurring within the first 32-36 weeks [2]. Patients commonly report profound changes in eating behaviour, including complete loss of food preoccupation, comfortable adherence to calorie-restricted diets, and sustained satiety from small meals.

Side effects at 10mg are typically consistent with those experienced at 7.5mg, as most gastrointestinal adaptation has already occurred. New-onset nausea at this dose is uncommon unless dietary habits change significantly. Your UK prescriber will assess your 16-week results to determine whether 10mg serves as your optimal maintenance dose or if escalation to the maximum 15mg dose would provide additional clinical benefit.

Weeks 17-20 and Beyond: Mounjaro 12.5mg and 15mg Maintenance Doses

For patients requiring maximum therapeutic effect, Mounjaro offers 12.5mg and 15mg weekly maintenance doses [1]. The 12.5mg dose serves as an intermediate option, whilst 15mg represents the highest licensed dose in the UK. Escalation to these levels occurs only after successful completion of lower doses with good tolerability.

Clinical trial data showed average weight reduction of 20.9% at the 15mg dose over 72 weeks in the SURMOUNT-1 trial—the highest efficacy observed in any obesity pharmacotherapy study to date [2]. These maximum doses produce the most profound appetite suppression and metabolic improvements, though individual response varies considerably.

Once you reach your maintenance dose (whether 10mg, 12.5mg, or 15mg), you'll continue weekly injections indefinitely to sustain weight loss [1]. Discontinuing Mounjaro typically results in gradual weight regain, as the medication does not cure the underlying metabolic factors driving obesity. Your Cured Pharmacy prescriber will conduct regular reviews to monitor ongoing efficacy, side effects, and whether dose adjustments are needed based on your evolving clinical picture.

Long-Term Maintenance and Dose Optimisation

Maintenance therapy with Mounjaro is designed for long-term use, with clinical trials demonstrating sustained efficacy and safety for at least 72 weeks [2]. Some patients find their optimal dose is lower than 15mg—there's no requirement to escalate to the maximum if you've achieved your goals at a lower level. Your UK prescriber will work with you to identify the minimum effective dose that maintains your weight loss whilst minimising side effects and treatment costs.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/14881 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and must be prescribed following an online consultation with a UK prescriber at Cured Pharmacy.